• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,155.62 347.14
( 0.45%)
Global Indices
Nasdaq
52,022.73 330.70
(0.64%)
Dow Jones
7,531.82 -43.47
(-0.57%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,505.62 11.41
(0.11%)
Forex
USD-INR
94.63 -0.29
(-0.31%)
EUR-INR
109.79 -0.04
(-0.03%)
GBP-INR
127.09 -0.16
(-0.13%)
JPY-INR
0.59 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.5524281
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
37.43
58.01
EPS(TTM)
Face Value()
Div & Yield %
1.08
10
0
 

hindustan unilever ltd
Clean Science & Technology consolidated net profit declines 21.35% in the March 2026 quarter
May 14,2026
Net profit of Clean Science & Technology declined 21.35% to Rs 58.27 crore in the quarter ended March 2026 as against Rs 74.09 crore during the previous quarter ended March 2025. Sales declined 5.47% to Rs 249.25 crore in the quarter ended March 2026 as against Rs 263.68 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.14% to Rs 229.66 crore in the year ended March 2026 as against Rs 264.41 crore during the previous year ended March 2025. Sales declined 1.04% to Rs 956.55 crore in the year ended March 2026 as against Rs 966.64 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales249.25263.68 -5 956.55966.64 -1
OPM %38.4239.74 -37.1240.10 -
PBDT98.51117.03 -16 387.25425.79 -9
PBT77.6999.58 -22 309.67356.73 -13
NP58.2774.09 -21 229.66264.41 -13